Anxiety disorder.
Gale
C
C
University of Auckland, Auckland, New Zealand. c.gale@auckland.ac.nz
Oakley-Browne
M
M
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy / Q000628:therapy*; D001569:Benzodiazepines / Q000627:therapeutic use*; D002065:Buspirone / Q000627:therapeutic use; D015928:Cognitive Behavioral Therapy / Q000379:methods*; D006801:Humans
D000319:Adrenergic beta-Antagonists; D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D001569:Benzodiazepines; D002065:Buspirone